Apyx Medical (NASDAQ:APYX) Shares Up 1.4% – Here’s Why

Apyx Medical Co. (NASDAQ:APYXGet Free Report) shares were up 1.4% during mid-day trading on Tuesday . The company traded as high as $1.44 and last traded at $1.44. Approximately 30,903 shares changed hands during trading, a decline of 18% from the average daily volume of 37,894 shares. The stock had previously closed at $1.42.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on APYX shares. Craig Hallum raised shares of Apyx Medical to a “strong-buy” rating in a report on Thursday, October 24th. BTIG Research started coverage on shares of Apyx Medical in a report on Thursday, October 17th. They issued a “neutral” rating on the stock.

Get Our Latest Analysis on Apyx Medical

Apyx Medical Price Performance

The company has a market capitalization of $54.20 million, a price-to-earnings ratio of -1.73 and a beta of 1.26. The stock has a fifty day simple moving average of $1.58 and a 200-day simple moving average of $1.36. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52.

Apyx Medical (NASDAQ:APYXGet Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. The firm had revenue of $11.49 million for the quarter, compared to the consensus estimate of $11.66 million. During the same period in the prior year, the firm posted ($0.13) earnings per share. On average, equities research analysts anticipate that Apyx Medical Co. will post -0.68 EPS for the current year.

Institutional Trading of Apyx Medical

Institutional investors have recently bought and sold shares of the business. Kingsview Wealth Management LLC lifted its position in shares of Apyx Medical by 8.7% during the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock valued at $214,000 after buying an additional 10,800 shares in the last quarter. Private Advisor Group LLC grew its position in shares of Apyx Medical by 3.9% in the third quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock valued at $400,000 after purchasing an additional 12,180 shares during the period. Finally, Royce & Associates LP increased its stake in shares of Apyx Medical by 3.4% during the third quarter. Royce & Associates LP now owns 2,582,490 shares of the company’s stock worth $3,202,000 after purchasing an additional 85,267 shares in the last quarter. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Company Profile

(Get Free Report)

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.

Featured Stories

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.